Gestión Bout III Meridion Ptr Glb FI
Portfolio
Holdings
Symbol | Name | Country | Sector | Industry | Most recent quarter | % of Total Shares | % of Total Assets | Shares | Book Value | Market Price Value | Fundamental Score | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ALVR.NASDAQ | Allovir Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 0.062 | 2.776 | 72k | $75.7k | $30.2k |
| |||||||||||||
ENZ.NYSE | Enzo Biochem Inc | USA | Healthcare | Diagnostics & Research | 2024-10-31 | 0.086 | 2.15 | 45.1k | $41.1k | $32.2k |
|
Trades
Adds
Report date: 2024-09-30
Trade | Current | |||||
---|---|---|---|---|---|---|
Symbol | Shares | % | Total | $ Range | Price | % |
ENZ.NYSE | 11k | 32.3 | 12.3k | 1-1 | $0.71 | -28.2% |
Comments
How you think about this?